These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 27694641

  • 1. Aripiprazole-related hyponatremia and consequent valproic acid-related hyperammonemia in one patient.
    Lin MW, Chang C, Yeh CB, Tai YM, Chang HA, Kao YC, Tzeng NS.
    Aust N Z J Psychiatry; 2017 Mar; 51(3):296-297. PubMed ID: 27694641
    [No Abstract] [Full Text] [Related]

  • 2. Hyperammonemia induced by interaction of valproate and quetiapine.
    Halaby A, Haddad R, Naja WJ.
    Curr Drug Saf; 2013 Sep; 8(4):284-6. PubMed ID: 23962184
    [Abstract] [Full Text] [Related]

  • 3. Ammonia induced encephalopathy from valproic acid in a bipolar patient: case report.
    Elgudin L, Hall Y, Schubert D.
    Int J Psychiatry Med; 2003 Sep; 33(1):91-6. PubMed ID: 12906346
    [Abstract] [Full Text] [Related]

  • 4. Ammonemia in bipolar patients on maintenance treatment with valproic acid.
    Bocchetta A, Siddu A, Sardu C, Sarnicola A, Martinelli V.
    J Clin Psychopharmacol; 2012 Feb; 32(1):148-50. PubMed ID: 22217957
    [No Abstract] [Full Text] [Related]

  • 5. Valproate-related hyperammonemic encephalopathy: report of 1 case.
    Selvi Y, Annagur BB, Sayin AA, Akbaba N.
    J Clin Psychopharmacol; 2014 Jun; 34(3):e1. PubMed ID: 24633004
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bipolar disorder and valproate-induced hyperammonemic encephalopathy in an adolescent with diabetes.
    Young L, Coffey BJ.
    J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):449-52. PubMed ID: 20973717
    [No Abstract] [Full Text] [Related]

  • 8. Decoding the enigma: Valproate encephalopathy in a bipolar affective disorder without hyperammonemia.
    Sousa BSGC, de Sá ZC, Ramos J.
    Bipolar Disord; 2024 Aug; 26(5):507-509. PubMed ID: 38825712
    [No Abstract] [Full Text] [Related]

  • 9. Valproate-induced hyperammonemic encephalopathy associated with urinary tract infection and urinary retention in the psychiatric setting.
    Dawson LP, Lee SJ, Hollander YS.
    Aust N Z J Psychiatry; 2016 Nov; 50(11):1110. PubMed ID: 27056174
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pediatric bipolar disorder: evidence-based psychopharmacological treatments.
    Banuelos-Arzac C.
    J Child Adolesc Psychiatr Nurs; 2008 May; 21(2):68. PubMed ID: 18429835
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Valproic acid-associated hyperammonemic encephalopathy: a case report from the psychiatric setting.
    Kimmel RJ, Irwin SA, Meyer JM.
    Int Clin Psychopharmacol; 2005 Jan; 20(1):57-8. PubMed ID: 15602119
    [Abstract] [Full Text] [Related]

  • 14. Pedal edema associated with addition of low-dose quetiapine to valproate treatment in bipolar disorder.
    Chen CY, Yeh YW, Kuo SC, Shiah IS, Liu PY, Chen CL.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov 13; 33(8):1551-2. PubMed ID: 19665043
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hyperammonemia associated with valproic acid use in elderly psychiatric patients.
    Holroyd S, Overdyke JT.
    J Neuropsychiatry Clin Neurosci; 2012 Nov 13; 24(3):372-4. PubMed ID: 23037652
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical alertness to valproic acid-induced hyperammonemia--two case reports.
    Shan JC, Hsieh MH, Liu CC, Wen CC, Liu CM.
    J Psychopharmacol; 2010 Jun 13; 24(6):943-5. PubMed ID: 19304858
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.